|
The complaint investigation for falsely decreased total bilirubin results, while using total bilirubin reagent, included a review of data and information provided by the customer, ticket trending review, labeling review, and device history record review.Trending review determined no related trend for falsely elevated results for the product.Return testing was not completed as returns were not available.A review of the product labeling concluded that the issue is sufficiently addressed.Manufacturing documentation for the likely cause list number were reviewed and did not identify any issues.File samples were not tested, as the repeat test at the customer site produced an acceptable result.In addition, the quality control was acceptable during the falsely depressed result.This indicates the assay is performing as expected.Based on all available information and abbott diagnostics' complaint investigation, no systemic issue or product deficiency with the total bilirubin reagent, list number 06l45, was identified.
|